Free Trial

Fresenius Medical Care (FMS) Stock Forecast & Price Target

Fresenius Medical Care logo
$21.79 -0.31 (-1.40%)
(As of 11/20/2024 ET)

Fresenius Medical Care - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
2
Buy
1

Based on 4 Wall Street analysts who have issued ratings for Fresenius Medical Care in the last 12 months, the stock has a consensus rating of "Hold." Out of the 4 analysts, 1 has given a sell rating, 2 have given a hold rating, and 1 has given a buy rating for FMS.

Consensus Price Target

$24.30
11.52% Upside
According to the 4 analysts' twelve-month price targets for Fresenius Medical Care, the average price target is $24.30. The highest price target for FMS is $25.60, while the lowest price target for FMS is $23.00. The average price target represents a forecasted upside of 11.52% from the current price of $21.79.
Get the Latest News and Ratings for FMS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Fresenius Medical Care and its competitors.

Sign Up

FMS Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
5 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$24.30$23.00$22.00$17.85
Forecasted Upside11.52% Upside10.10% Upside13.11% Upside-9.62% Downside
Consensus Rating
Hold
Hold
Hold
Hold

FMS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

FMS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Fresenius Medical Care Stock vs. The Competition

TypeFresenius Medical CareMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.80
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside11.52% Upside26,931.56% Upside9.83% Upside
News Sentiment Rating
Positive News

See Recent FMS News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/6/2024Berenberg Bank
2 of 5 stars
V. Lambert
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$25.60+25.98%
10/7/2024Truist Financial
2 of 5 stars
 Boost TargetHold ➝ Hold$22.00 ➝ $23.00+10.79%
1/8/2024Morgan Stanley
3 of 5 stars
 DowngradeEqual Weight ➝ Underweight
11/24/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeReduce ➝ Hold
11/17/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
9/13/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Neutral
8/1/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral
7/12/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy
4/28/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Hold
3/7/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform
1/2/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Underperform$14.00 ➝ $11.70-28.40%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:44 AM ET.


FMS Forecast - Frequently Asked Questions

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Fresenius Medical Care is $24.30, with a high forecast of $25.60 and a low forecast of $23.00.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care in the last twelve months. There is currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.

According to analysts, Fresenius Medical Care's stock has a predicted upside of 11.52% based on their 12-month stock forecasts.

Fresenius Medical Care has been rated by research analysts at Berenberg Bank, and Truist Financial in the past 90 days.

Analysts like Fresenius Medical Care less than other "medical" companies. The consensus rating for Fresenius Medical Care is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how FMS compares to other companies.


This page (NYSE:FMS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners